CoChat
Sign Up
Cited by 190

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

N‐myc downstream regulated gene 1 modulates Wnt‐β‐catenin signalling and pleiotropically suppresses metastasis

Liu, Wen, Xing, Fei, Iiizumi‐Gairani, Megumi, Okuda, Hiroshi, Watabe, Misako, Pai, Sudha K., Pandey, Puspa R., Hirota, Shigeru, Kobayashi, Aya, Mo, Yin‐Yuan, Fukuda, Koji, Li, Yi, Watabe, Kounosuke·2012·EMBO Molecular Medicine
DOI 10.1002/emmm.201100190PMC PMC3306556
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/emmm.201100190

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 8 references

Research works printed but not linked: 50

  1. Arenas MI, Romo E, Royuela M, Fraile B, Paniagua R (2000) E‐, N‐ and P‐cadherin, and alpha‐, beta‐ and gamma‐catenin protein expression in normal, hyperplastic and carcinomatous human prostate. Histochem J 32: 659‐667 · DOI
  2. Bahmanyar S, Kaplan DD, Deluca JG, Giddings TH, Jr, O'Toole ET, Winey M, Salmon ED, Casey PJ, Nelson WJ, Barth AI (2008) Beta‐catenin is a Nek2 substrate involved in centrosome separation. Genes Dev 22: 91‐105 · DOI
  3. Bandyopadhyay S, Pai SK, Gross SC, Hirota S, Hosobe S, Miura K, Saito K, Commes T, Hayashi S, Watabe M, et al (2003) The Drg‐1 gene suppresses tumor metastasis in prostate cancer. Cancer Res 63: 1731‐1736
  4. Bandyopadhyay S, Wang Y, Zhan R, Pai SK, Watabe M, Iiizumi M, Furuta E, Mohinta S, Liu W, Hirota S, et al (2006a) The tumor metastasis suppressor gene Drg‐1 down‐regulates the expression of activating transcription factor 3 in prostate cancer. Cancer Res 66: 11983‐11990 · DOI
  5. Bandyopadhyay S, Zhan R, Chaudhuri A, Watabe M, Pai SK, Hirota S, Hosobe S, Tsukada T, Miura K, Takano Y, et al (2006b) Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression. Nat Med 12: 933‐938 · DOI
  6. Berger JC, Vander Griend DJ, Robinson VL, Hickson JA, Rinker‐Schaeffer CW (2005) Metastasis suppressor genes: from gene identification to protein function and regulation. Cancer Biol Ther 4: 805‐812 · DOI
  7. Bismar TA, Humphrey PA, Grignon DJ, Wang HL (2004) Expression of beta‐catenin in prostatic adenocarcinomas: a comparison with colorectal adenocarcinomas. Am J Clin Pathol 121: 557‐563 · DOI
  8. Clevers H (2006) Wnt/beta‐catenin signaling in development and disease. Cell 127: 469‐480 · DOI · Paper page
  9. Davidson G, Wu W, Shen J, Bilic J, Fenger U, Stannek P, Glinka A, Niehrs C (2005) Casein kinase 1 gamma couples Wnt receptor activation to cytoplasmic signal transduction. Nature 438: 867‐872 · DOI
  10. De la Taille A, Rubin MA, Chen MW, Vacherot F, de Medina SG, Burchardt M, Buttyan R, Chopin D (2003) Beta‐catenin‐related anomalies in apoptosis‐resistant and hormone‐refractory prostate cancer cells. Clin Cancer Res 9: 1801‐1807
  11. DiMeo TA, Anderson K, Phadke P, Feng C, Perou CM, Naber S, Kuperwasser C (2009) A novel lung metastasis signature links Wnt signaling with cancer cell self‐renewal and epithelial–mesenchymal transition in basal‐like breast cancer. Cancer Res 69: 5364‐5373 · DOI
  12. Dolled‐Filhart M, McCabe A, Giltnane J, Cregger M, Camp RL, Rimm DL (2006) Quantitative in situ analysis of beta‐catenin expression in breast cancer shows decreased expression is associated with poor outcome. Cancer Res 66: 5487‐5494 · DOI
  13. Doucas H, Garcea G, Neal CP, Manson MM, Berry DP (2005) Changes in the Wnt signalling pathway in gastrointestinal cancers and their prognostic significance. Eur J Cancer 41: 365‐379 · DOI
  14. Ellen TP, Ke Q, Zhang P, Costa M (2008) NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states. Carcinogenesis 29: 2‐8 · DOI
  15. Fritzmann J, Morkel M, Besser D, Budczies J, Kosel F, Brembeck FH, Stein U, Fichtner I, Schlag PM, Birchmeier W (2009) A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential. Gastroenterology 137: 165‐175 · DOI
  16. Heuberger J, Birchmeier W (2010) Interplay of cadherin‐mediated cell adhesion and canonical Wnt signaling. Cold Spring Harb Perspect Biol 2: 1‐24 · DOI
  17. Hoshida Y, Nijman SM, Kobayashi M, Chan JA, Brunet JP, Chiang DY, Villanueva A, Newell P, Ikeda K, Hashimoto M, et al (2009) Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma. Cancer Res 69: 7385‐7392 · DOI · Paper page
  18. Iiizumi M, Liu W, Pai SK, Furuta E, Watabe K (2008) Drug development against metastasis‐related genes and their pathways: a rationale for cancer therapy. Biochim Biophys Acta 1786: 87‐104
  19. Inomata M, Ochiai A, Akimoto S, Kitano S, Hirohashi S (1996) Alteration of beta‐catenin expression in colonic epithelial cells of familial adenomatous polyposis patients. Cancer Res 56: 2213‐2217
  20. Khew‐Goodall Y, Goodall GJ (2010) Myc‐modulated miR‐9 makes more metastases. Nat Cell Biol 12: 209‐211 · DOI
  21. Khramtsov AI, Khramtsova GF, Tretiakova M, Huo D, Olopade OI, Goss KH (2010) Wnt/beta‐catenin pathway activation is enriched in basal‐like breast cancers and predicts poor outcome. Am J Pathol 176: 2911‐2920 · DOI
  22. Kitowska A, Pawełczyk T (2010) N‐myc downstream regulated 1 gene and its place in the cellular machinery. Acta Biochim Pol 57: 15‐21 · DOI
  23. Klaus A, Birchmeier W (2008) Wnt signaling and its impact on development and cancer. Nat Rev Cancer 8: 387‐398 · DOI · Paper page
  24. Klein CA (2009) Parallel progression of primary tumours and metastases. Nat Rev Cancer 9: 302‐312 · DOI
  25. Kovacevic Z, Richardson DR (2006) The metastasis suppressor, Ndrg‐1: a new ally in the fight against cancer. Carcinogenesis 27: 2355‐2366 · DOI
  26. Le NT, Richardson DR (2004) Iron chelators with high antiproliferative activity up‐regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation. Blood 104: 2967‐2975
  27. Li Y, Hively WP, Varmus HE (2000) Use of MMTV‐Wnt‐1 transgenic mice for studying the genetic basis of breast cancer. Oncogene 19: 1002‐1009 · DOI
  28. Logan CY, Nusse R (2004) The Wnt signaling pathway in development and disease. Ann Rev Cell Dev Biol 20: 781‐810 · DOI · Paper page
  29. López‐Knowles E, Zardawi SJ, McNeil CM, Millar EK, Crea P, Musgrove EA, Sutherland RL, O'Toole SA (2010) Cytoplasmic localization of beta‐catenin is a marker of poor outcome in breast cancer patients. Cancer Epidemiol Biomarkers Prev 19: 301‐309 · DOI
  30. Mani M, Carrasco DE, Zhang Y, Takada K, Gatt ME, Dutta‐Simmons J, Ikeda H, Diaz‐Griffero F, Pena‐Cruz V, Bertagnolli M, et al (2009) Bcl9 promotes tumor progression by conferring enhanced proliferative, metastatic, and angiogenic properties to cancer cells. Cancer Res 69: 7577‐7586 · DOI
  31. Nash KT, Welch DR (2006) The KISS1 metastasis suppressor: mechanistic insights and clinical utility. Front Biosci 11: 647‐659 · DOI
  32. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F, et al (2006) A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 10: 515‐527 · DOI
  33. Nguyen DX, Chiang AC, Zhang XH, Kim JY, Kris MG, Ladanyi M, Gerald WL, Massagué J (2009) NT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. Cell 138: 51‐62 · DOI
  34. Norton L, Massague J (2006) Is cancer a disease a self‐seeding? Nat Med 12: 875‐878 · DOI
  35. Riethmüller G, Klein CA (2001) Early cancer cell dissemination and late metastatic relapse: clinical reflections and biological approaches to the dormancy problem in patients. Semin Cancer Biol 11: 307‐311 · DOI
  36. Sherbet GV (2009) Metastasis promoter S100A4 is a potentially valuable molecular target for cancer therapy. Cancer Lett 280: 15‐30 · DOI
  37. Shevde LA, Welch DR (2003) Metastasis suppressor pathways—an evolving paradigm. Cancer Lett 198: 1‐20 · DOI
  38. Steeg PS (2003) Metastasis suppressors alter the signal transduction of cancer cells. Nat Rev Cancer 3: 55‐63 · DOI
  39. Steeg PS (2006) Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12: 895‐904 · DOI
  40. Stein U, Arlt F, Walther W, Smith J, Waldman T, Harris ED, Mertins SD, Heizmann CW, Allard D, Birchmeier W, et al (2006) The metastasis‐associated gene S100A4 is a novel target of beta‐catenin/T‐cell factor signaling in colon cancer. Gastroenterology 131: 1486‐1500 · DOI
  41. Tamai K, Zeng X, Liu C, Zhang X, Harada Y, Chang Z, He X (2004) A mechanism for Wnt coreceptor activation. Mol Cell 13: 149‐156 · DOI · Paper page
  42. Togo N, Ohwada S, Sakurai S, Toya H, Sakamoto I, Yamada T, Nakano T, Muroya K, Takeyoshi I, Nakajima T, et al (2008) Prognostic significance of BMP and activin membrane‐bound inhibitor in colorectal cancer. Gastroenterology 14: 4880‐4888
  43. Van Belzen N, Dinjens WN, Diesveld MP, Groen NA, van der Made AC, Nozawa Y, Vlietstra R, Trapman J, Bosman FT (1997) A novel gene which is up‐regulated during colon epithelial cell differentiation and down‐regulated in colorectal neoplasms. Lab Invest 77: 85‐92
  44. Vincan E, Barker N (2008) The upstream components of the Wnt signalling pathway in the dynamic EMT and MET associated with colorectal cancer progression. Clin Exp Metastasis 25: 657‐663 · DOI
  45. Whitnall M, Howard J, Ponka P, Richardson DR (2006) A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics. Proc Natl Acad Sci USA 103: 14901‐14906 · DOI
  46. Whittaker S, Marais R, Zhu AX (2010) The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene 29: 4989‐5005 · DOI
  47. Yan L, Coletta LD, Powell KL, Shen Jj, Thames H, Aldaz CM, Macleod MC (2011) Activation of the canonical Wnt/β‐catenin pathway in ATF3‐induced mammary tumors. PLos One 6: e16515 · DOI
  48. Yin X, Dewille JW, Hai T (2008) A potential dichotomous role of ATF3, an adaptive‐response gene, in cancer development. Oncogene 27: 2118‐2127 · DOI
  49. Zeng X, Tamai K, Doble B, Li S, Huang H, Habas R, Okamura H, Woodgett J, He X (2005) A dual‐kinase mechanism for Wnt co‐receptor phosphorylation and activation. Nature 438: 873‐877 · DOI
  50. Zhang XH, Wang Q, Gerald W, Hudis CA, Norton L, Smid M, Foekens JA, Massague J (2009) Latent bone metastasis in breast cancer tied to Src‐dependent survival signals. Cancer Cell 16: 67‐78 · DOI

Cited by

Sorted by citations

See all 190

Metadata

Authors
Liu, W., Xing, F., Iiizumi‐Gairani, M., Okuda, H., Watabe, M., Pai, S. K., Pandey, P. R., Hirota, S., Kobayashi, A., Mo, Y., Fukuda, K., Li, Y., & Watabe, K.
Venue
EMBO Molecular Medicine
Publisher
Springer Science and Business Media LLC
Published
2012-01-13
Volume
4
Issue
2
Pages
93-108
ISSN
  • 1757-4676
  • 1757-4684
DOI
10.1002/emmm.201100190
PMC
PMC3306556
Cited by
190
References
8
Language
en
Licence
Funders
  • NIH (R01CA124650, R01CA129000 to KW)
  • US Department of Defense (PC031038, BC044370, PC061256, PC073640 to KW)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review